Immune cells use steroids

Type 2 T-helper cells produce a steroid to turn themselves off

Immune cells use steroids

140508-steroids.jpgNational Institute of Allergy and Infectious Diseases (NIAID)
Scanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system. These cells appear to produce a steroid to turn themselves off once the infection has been cleared.

Researchers at the Wellcome Trust Sanger Institute and the European Bioinformatics Institute (EMBL-EBI) have discovered that some immune cells turn themselves off by producing a steroid. The findings have implications for the study of cancers, autoimmune diseases and parasitic infections.

The scientists in the Sanger Institute-EBI Single-Cell Genomics Centre looked at the activity of genes in Th2 immune cells during parasitic infection and saw that, at a certain point, these cells produce a steroid called pregnenolone, which is involved in suppressing the immune response.

"We were really surprised to see that these immune cells are producing a steroid. In cell culture, we see that the steroids play a part in regulating T cell proliferation. We had already seen that T-helper cells were producing steroids, but initially we were blind - what was going on?"

Dr Bidesh Mahata, a member of Sarah Teichmann's research group at the Sanger Institute and EMBL-EBI

The study used single-cell sequencing data and sophisticated statistical methods to confirm for the first time that the immune cells are able to self-regulate once they have finished battling infection.

"Because we had access to data from single-cell sequencing experiments, we could conduct deep statistical analyses on a very large and comprehensive dataset. That pointed us to the genes involved in pregnenolone production at the point when Th2 cells are being produced, and we could deduce that the Th2 cells themselves were involved in immunosuppression."

Dr Sarah Teichmann, Faculty member of the Sanger Institute and Senior Group Leader at EMBL-EBI

The researchers suggest that bringing the immune system back into balance is an intrinsic part of this particular immune response.

"We confirmed our findings experimentally, showing that pregnenolone inhibits both Th cell proliferation and B cell immunoglobulin class switching. We think this points to the idea that Th2 cells differentiate into steroid-producing cells as part of a larger mechanism to bring the immune system back into balance."

Dr Bidesh Mahata

The findings from this study are strengthened by those of the Gelfand group at National Jewish Health in Denver, US. The next step for the team is to investigate how the process starts, what other tissues are involved and which types of infection give rise to this response.

Notes to Editors
  • Single-cell RNA sequencing reveals T helper cells synthesizing steroids de novo to contribute to immune homeostasis.

    Mahata B, Zhang X, Kolodziejczyk AA, Proserpio V, Haim-Vilmovsky L et al.

    Cell reports 2014;7;4;1130-42


Please see the paper for a full list of funding bodies.

Participating Centres

Please see the paper for a full list of participating centres.

Selected Websites
Contact the Press Office

Emily Mobley, Media Manager

Tel +44 (0)1223 496 851

Dr Samantha Wynne, Media Officer

Tel +44 (0)1223 492 368

Dr Matthew Midgley, Media Officer

Tel +44 (0)1223 494 856

Wellcome Sanger Institute,
CB10 1SA,

Mobile +44 (0)7900 607793

Recent News

UK launches whole genome sequence alliance to map spread of coronavirus
The Wellcome Sanger Institute will collaborate with expert groups across the country to analyse the genetic code of COVID-19 samples circulating in the UK, providing public health agencies with a unique tool to combat the virus
Sanger Institute scientist wins 2021 Biochemical Society award
Roser Vento-Tormo awarded an Early Career Research Award
Sanger Institute and Wellcome Genome Campus temporarily closed to all but critical research
In response to the rapidly changing COVID-19 pandemic, the Sanger Institute and its neighbours on the Wellcome Genome Campus will close all but critical and essential operations from Friday 20 March.